Médecins Sans Frontières/Doctors without Borders (MSF) has started to roll out a new HIV prevention tool: a long-acting injectable pre-exposure prophylaxis. If we can get this drug to people at risk ...

A new comparative study led by researchers at the UNC School of Medicine found that a new therapy for prevention of recurrent ...

The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, Lenacapavir, has shown ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...

Here, we show that accumulation of mutations in a drug-resistant HIV-1 protease (HIV-1 PR) variant, D30N/M36I/A71V, changes the fractional occupancy of the equilibrium conformational sampling ensemble ...

Currently, there are only limited FDA-approved drugs for GB, such as TMZ, Bevacizumab, CCNU, and BiCNU, highlighting the urgent need for new treatment options for GB. One of the most promising ...

A UVa researcher has discovered that NRTIs, drugs used to treat HIV, can also help prevent Alzheimer's and a long list of ...

Several studies have described improved outcomes for HIV-infected patients admitted to the intensive care unit (ICU) since the introduction of highly active antiretroviral therapy (HAART). A study was ...

For many, the fear of social exclusion or cultural taboos discouraged them from both testing for HIV and adhering to ART treatment: There are people who say that there is a traditional treatment ...

The administration has made policy changes that could impact HIV prevention and treatment efforts in Florida. South Florida has one of the highest HIV and AIDS infection rates in the country. The ...